ZBIO
$28.18+5.50%
Zenas BioPharma Inc.Stock · HealthcareRussell 2000 · 0.02% of IWMNasdaq Composite · 0.003% of ONEQUS Stock Market · 0.0010% of VTIRussell 3000 · 0.0006% of IWV
Zenas BioPharma Inc. total returns by year (including dividends)
As of market close, Oct 20, 2026
Zenas BioPharma Inc. total returns by year (2025–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $36.31 | $28.18 | 0.0% | -22.4% | |
| 2025 | $8.19 | $36.31 | 0.0% | +343.3% |
- Annualized
- +28.2%
- 2025–2026
- Average year
- +343.3%
- 1 full years
- Best year
- +343.3%
- 2025
- Worst year
- +343.3%
- 2025
- Positive years
- 1/1
- 100% up
Annualized (CAGR)
+28.2%
2025–2026
Average year
+343.3%
1 full years
Best year
+343.3%
2025
Worst year
+343.3%
2025
Positive years
1/1
100% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
2025+343%'25
2026-22%'26
Methodology#
Total returns, dividends reinvested, measured on ZBIO. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Zenas BioPharma Inc.'s average annual return?
- Since 2025, Zenas BioPharma Inc. (ZBIO) has returned about 28.2% a year (the compound annual growth rate) and an average calendar-year return of 343.3%.
- What were Zenas BioPharma Inc.'s best and worst years?
- Over 2025–2026, the best year was 2025 (+343.3%) and the worst was 2025 (+343.3%).
- How often is Zenas BioPharma Inc. up in a year?
- 1 of the 1 full years since 2025 were positive — about 100% of the time.
More on Zenas BioPharma Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100